Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
66.935
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
5
9
$11-$25k
0
4,510
3,092.8125
3,460.1582
7
white
23.097656
26
0.622925
0.437988
1
0
0
yes
0.75
0.5
dnr after sadm
1
53
19
110
25
36.59375
160
2
3.399902
2.599609
132
7.339844
195
54
3,200
0
1
null
1
106
1
70.02594
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
null
0
25,514
16,332.7109
17,291.6562
21.5
white
25.796875
30
0.702881
0.612915
8
1
0
no
null
null
no dnr
11
67
7.5
122
24
35.69531
null
3.899902
0.5
1
136
null
124
13
1,800
null
0
no(M2 and SIP pres)
0
930
0
62.35699
female
0
4
COPD
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
4,064
2,609.4922
4,002.37891
18
white
23.597656
26
0.796997
0.672974
1
0
0
yes
0.8
0.7
no dnr
4
67
null
101
40
35.59375
null
null
null
1.299805
134
null
90
27
null
1
2
null
2
929
0
83.948
male
0
4
Coma
Coma
3
8
null
41
4,574
3,325.3496
3,421.06836
16
white
17.898438
23
0.494995
0.422974
1
0
1
no
0.9
0.9
dnr before sadm
-1
63
14.898438
144
28
39.29688
77.64062
2
9.398438
0.799927
133
7.349609
143
10
2,375
null
4
null
4
454
1
69.10895
male
0
4
Colon Cancer
Cancer
5
12
$11-$25k
0
5,263
3,212.4961
2,303.7793
11
white
13.898438
20
0.8479
0.664917
1
1
0
metastatic
0.7
0.4
no dnr
4
143
null
118
28
36.69531
117.5
null
null
1.699951
124
7.319336
157
34
430
1
null
no(M2 and SIP pres)
1.166748
69
1
56.41599
male
0
46
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
null
9
90,783
60,371.0625
61,435.9688
44.75
white
34.59375
75
0.612915
0.507935
1
0
0
no
0.2
0.2
no dnr
46
59
9.798828
102
24
36.19531
78.75
2.199707
0.199982
0.899902
133
7.419922
116
12
2,750
null
null
no(M2 and SIP pres)
2.265137
929
0
87.15698
male
0
22
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
66,731
44,561.1875
44,812.0938
32.666657
white
31.097656
41
0.362
0.169983
9
0
0
no
0.8
0.8
no dnr
22
73
7.399414
64
20
36.39844
null
null
1.399902
1.699951
139
null
200
39
2,300
null
0
no(M2 and SIP pres)
0
927
0
76.02496
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
null
100
98,962
66,981.1875
69,277.75
35
white
20.199219
25
0.313965
0.199982
22
1
0
no
0.6
0.5
dnr after sadm
2
148
9.298828
104
28
35.59375
240
4.699219
0.599976
1.699951
147
7.369141
106
29
1,025
null
0
<2 mo. follow-up
0
17
1
72.48199
female
1
42
COPD
COPD/CHF/Cirrhosis
3
12
null
0
72,553
49,537.2188
44,304.6562
20.25
white
23.597656
35
0.775879
0.642944
1
0
0
no
0.8
0.6
no dnr
42
77
8.599609
67
28
35.89844
null
null
null
1
139
null
115
18
1,470
5
6
<2 mo. follow-up
6
42
1
70.92096
female
0
7
MOSF w/Malig
ARF/MOSF
2
null
null
0
5,492
4,187.9258
3,486.75
8.5
white
21
45
0.747925
0.668945
1
0
0
yes
0.7
0.5
no dnr
7
67
12.699219
107
28
36.39844
null
null
null
1.199951
129
null
242
22
3,550
null
null
null
1.882568
491
1
71.26099
male
1
3
MOSF w/Malig
ARF/MOSF
1
3
$11-$25k
44
70,697
48,408.125
47,537.3438
46
white
41.5
87
0.017998
0.004
16
0
0
yes
0.5
0.5
no dnr
3
59
25.699219
70
40
36.39844
200
null
null
2.099609
130
7.399414
138
37
385
null
null
<2 mo. follow-up
2.432129
3
1
43.31799
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
21,711
14,850.7891
15,784.6484
44.5
white
34.09375
50
0.726929
0.642944
1
1
0
no
0.05
0.04
no dnr
8
94
11.798828
76
20
35.69531
400
3.699707
0.5
1.099854
138
7.399414
144
32
1,500
null
null
<2 mo. follow-up
2.335938
8
1
85.82898
male
1
5
Coma
Coma
1
6
under $11k
100
3,794
2,479.2109
2,611.87891
26
white
18.597656
23
0.159973
0.106995
1
0
1
no
0.01
0
dnr after sadm
3
111
17
81
20
36.29688
null
null
null
1.099854
133
null
155
9
5,450
null
null
<2 mo. follow-up
4.825195
5
1
72.86798
female
0
15
Lung Cancer
Cancer
1
13
$11-$25k
0
10,252
6,784.1055
7,766.06641
3
white
9.599609
10
0.814941
0.602905
1
0
0
metastatic
0.9
0.75
dnr after sadm
12
50
12.898438
104
8
39.29688
273.3125
2.5
12.298828
2.299805
146
7.539062
123
51
1,850
3
5
no(M2 and SIP pres)
5
147
1
79.53998
male
0
10
Colon Cancer
Cancer
1
8
null
0
6,102
4,132.4961
3,950.33984
9
white
20.597656
28
0.726929
0.453979
1
0
0
metastatic
0.5
0.2
dnr after sadm
1
68
7.299805
81
28
38.59375
277.5
2.5
0.799927
1
138
7.419922
168
18
1,138
0
1
<2 mo. follow-up
1
43
1
59.88498
female
0
8
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
6,514
4,453.6914
4,030.6582
5.5
white
21
36
0.875977
0.793945
1
1
0
no
0.9
0.85
no dnr
8
66
18.597656
122
24
35.39844
233.3125
null
null
1.199951
135
7.489258
244
25
2,800
0
null
null
0.494751
83
1
52.42398
male
0
10
CHF
COPD/CHF/Cirrhosis
4
12
$25-$50k
0
8,569
5,841.957
5,122.45703
12
white
28.796875
45
0.793945
0.668945
1
1
0
no
0.75
0.5
no dnr
10
65
16.199219
70
24
39
244
3.599609
0.699951
0.899902
135
7.429688
159
12
2,775
3
2
no(M2 and SIP pres)
2
63
1
68.35297
female
0
7
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
4,881
3,302.4414
2,992.9082
5
white
18.296875
30
0.869995
0.783936
1
0
0
no
0.8
0.6
dnr after sadm
1
139
12.798828
59
24
36.29688
260
null
0.399963
1.699951
141
7.269531
175
49
3,350
0
0
no(M2 and SIP pres)
0
915
0
75.26398
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
13,348
8,931.6172
8,310.21875
12
white
17.5
31
0.845947
0.792969
2
0
0
no
0.8
0.8
no dnr
10
111
14
108
26
35.69531
130.59375
3.299805
6.5
2.199707
149
7.479492
128
45
2,310
null
null
null
2.265137
914
0
81.77399
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
null
41
68,292
44,787.375
44,734.9375
35.5
white
36.695313
69
0.136993
0.063995
10
0
0
no
0.6
0.6
dnr after sadm
6
96
9.699219
65
20
36.59375
null
3.799805
0.799927
1
134
null
311
19
null
null
null
<2 mo. follow-up
2.856445
11
1
47.23297
male
0
117
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
176,303
111,901.188
125,680
24.25
white
17.097656
24
0.893921
0.855957
8
0
0
no
0.6
0.5
dnr after sadm
86
103
5.699219
67
22
36.39844
213.03125
2.899902
3.699707
0.799927
141
7.389648
118
13
850
null
1
null
1
504
1
53.99899
female
0
32
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
89
65,056
44,875.375
44,177
31
white
33.796875
53
0.251953
0.14798
1
0
0
no
0.5
0.5
no dnr
32
43
19.597656
68
28
39.29688
376
null
null
1.899902
144
7.439453
176
43
2,625
null
0
no(M2 and SIP pres)
0
909
0
73.98199
male
0
6
CHF
COPD/CHF/Cirrhosis
2
8
under $11k
0
4,949
3,425.7734
2,402.29883
16
white
19.699219
23
0.837891
0.734985
1
0
0
no
null
null
no dnr
6
52
0.199982
142
26
39.09375
64
null
null
1.199951
142
7.359375
341
36
3,500
0
0
no(M2 and SIP pres)
0
909
0
73.41498
male
0
12
Lung Cancer
Cancer
4
12
null
0
8,663
5,505.293
4,598.4375
9.5
white
14.298828
8
0.73999
0.474976
1
1
0
metastatic
1
0.95
no dnr
12
122
7.799805
39
24
34.39844
null
null
null
2.699707
138
null
160
76
1,515
0
0
no(M2 and SIP pres)
0
181
1
76.63794
male
1
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
26
66,572
43,853.0312
42,930.1875
54.5
white
31.597656
53
0.382996
0.264954
10
0
0
no
0.7
0.65
no dnr
10
65
8
100
42
37
152.5
null
null
1.799805
140
7.419922
90
47
2,150
null
1
<2 mo. follow-up
1
10
1
60.008
male
0
9
CHF
COPD/CHF/Cirrhosis
8
14
null
0
5,204
3,598.4394
2,836.6582
7.5
white
23.097656
35
0.803955
0.68396
1
1
0
yes
0.8
0.6
no dnr
9
120
null
115
20
36.09375
null
null
null
0.699951
138
null
197
9
2,850
0
0
SIP>=30
0
392
1
68.88397
male
0
8
Lung Cancer
Cancer
1
8
$11-$25k
0
11,507
7,948.1367
6,828.77734
4
white
19.097656
12
0.653931
0.348999
1
0
0
metastatic
0.9
0.5
no dnr
8
56
6.699219
61
28
36.19531
null
3.899902
0.399963
2
136
null
98
36
null
null
1
adl>=4 (>=5 if sur)
1
214
1
75.97296
female
0
3
MOSF w/Malig
ARF/MOSF
1
12
$25-$50k
44
25,406
16,600.0938
16,141.4062
null
white
21.296875
31
0.399963
0.280945
6
0
0
metastatic
0
0
dnr after sadm
1
61
8.398438
98
34
36.79688
130.59375
null
null
4.799805
133
7.459961
106
95
3,050
null
null
adl>=4 (>=5 if sur)
2.910156
904
0
77.05096
male
0
5
Lung Cancer
Cancer
3
16
null
0
7,321
4,370.6797
4,709.70703
11
white
6.199219
8
0.850952
0.670898
1
0
0
metastatic
0.8
0.6
no dnr
5
73
12.599609
120
10
38.29688
211.09375
2.299805
1.199951
1.199951
136
7.529297
145
12
4,225
0
0
adl>=4 (>=5 if sur)
0
159
1
75.70197
male
0
12
COPD
COPD/CHF/Cirrhosis
3
15
$11-$25k
0
8,417
5,477.293
5,899.47656
10
white
14.5
26
0.873901
0.789917
1
0
0
no
0.5
0.4
dnr after sadm
5
69
5.5
71
28
36.19531
288.875
null
0.399963
1.299805
136
7.349609
175
42
1,100
3
2
adl>=4 (>=5 if sur)
2
109
1
59.409
male
0
31
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
null
26
89,880
61,031.75
59,264.6562
36
white
26.597656
36
0.66394
0.566895
4
0
0
no
0.6
0.6
no dnr
31
72
8.5
122
32
36.19531
null
null
null
0.899902
138
null
159
10
null
null
0
null
0
897
0
90.38495
male
0
11
CHF
COPD/CHF/Cirrhosis
5
8
null
0
11,069
7,677.5391
7,472.29688
29.5
white
51.898438
76
0.004
0
1
0
0
metastatic
0.1
0.05
dnr after sadm
4
69
14.699219
146
26
38.09375
null
2.599609
0.399963
0.899902
134
null
125
13
950
null
null
<2 mo. follow-up
4.542969
19
1
77.29498
male
0
9
CHF
COPD/CHF/Cirrhosis
3
8
$11-$25k
0
6,750
4,606.7539
3,212.67969
17.5
white
16.398438
31
0.863892
0.775879
1
0
0
no
0.5
0.5
no dnr
9
114
10.5
73
28
35.79688
null
3.299805
0.299988
1.399902
142
7.459961
181
18
null
1
0
no(M2 and SIP pres)
0
893
0
83.91498
male
0
10
CHF
COPD/CHF/Cirrhosis
5
null
null
0
6,141
4,087.0391
3,962.13867
9
white
22.097656
38
0.764893
0.626953
1
0
1
no
null
null
no dnr
10
77
28.597656
53
22
35.69531
null
null
1.199951
1.399902
132
null
150
20
2,525
null
null
null
5.938477
382
1
81.81195
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
under $11k
0
66,049
43,404
41,449.2812
55
white
36.695313
54
0.314941
0.201996
16
0
0
no
null
null
no dnr
8
110
4.899414
79
24
36.09375
null
null
null
1.599854
141
null
94
25
575
null
0
<2 mo. follow-up
0
8
1
73.75494
male
0
6
Colon Cancer
Cancer
2
6
under $11k
0
3,420
2,306.7441
2,380.10938
8
white
23.097656
14
0.694946
0.405945
1
0
0
metastatic
0.2
0.01
dnr after sadm
1
70
3
76
20
36.69531
null
null
0.399963
1.099854
140
null
null
null
null
null
1
<2 mo. follow-up
1
14
1
66.85596
female
0
3
COPD
COPD/CHF/Cirrhosis
2
null
null
0
1,968
1,304.7432
1,317.55957
null
white
15.798828
32
0.894897
0.824951
1
0
0
no
null
null
no dnr
3
73
9.599609
116
28
36.09375
177.125
2.599609
0.5
1.299805
131
7.359375
144
9
2,625
null
null
null
2.138184
530
1
76.68994
male
0
8
CHF
COPD/CHF/Cirrhosis
3
null
null
0
4,607
3,228.2344
2,411.64844
5.5
white
26.5
34
0.720947
0.565918
1
0
0
no
0.7
0.5
no dnr
8
107
16.597656
53
16
36.79688
null
null
null
0.799927
138
null
117
8
3,025
null
null
null
3.208008
891
0
67.07996
male
0
14
COPD
COPD/CHF/Cirrhosis
1
12
under $11k
0
13,903
7,774.2031
6,875.01953
6.666664
white
19.398438
32
0.861938
0.770996
1
0
0
no
null
null
no dnr
14
113
8.099609
107
24
36.29688
232
4.399414
0.799927
1.399902
140
7.369141
154
15
null
null
0
no(M2 and SIP pres)
0
890
0
45.125
male
0
11
MOSF w/Malig
ARF/MOSF
2
9
under $11k
0
52,438
34,762.4688
35,275.125
33.5
other
31.597656
34
0.42395
0.303955
27
0
0
yes
0.5
0.4
dnr after sadm
2
124
12.199219
162
35
38
217.125
3.199707
3.799805
4.199219
134
7.279297
163
55
3,675
null
0
<2 mo. follow-up
0
12
1
67.48499
female
0
4
CHF
COPD/CHF/Cirrhosis
4
null
null
0
2,125
1,470.4014
1,233.48926
7
white
17.398438
10
0.879883
0.800903
1
0
0
no
0.7
0.5
no dnr
4
104
12.398438
98
26
36.19531
483.3125
null
null
1.5
133
7.319336
112
19
2,555
0
null
null
0.494751
885
0
75.85797
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
null
41
72,352
46,216.5625
51,080.4062
30.333328
white
24.097656
28
0.541992
0.426941
7
0
0
no
0.5
0.5
no dnr
21
68
17
52
10
35.89844
172
null
null
1.399902
135
7.359375
103
50
1,075
null
0
no(M2 and SIP pres)
0
883
0
28.88199
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
under $11k
0
49,937
34,050.25
38,943.3125
30.333328
white
31.898438
51
0.776978
0.704956
6
1
0
no
0.5
0.5
no dnr
19
59
12.699219
115
26
39.29688
180
2.399902
0.299988
0.699951
145
7.479492
181
4
1,348
null
null
null
2.242676
290
1
70.18799
female
0
4
Lung Cancer
Cancer
2
13
null
0
3,494
2,189.0508
1,769.17969
9
white
14.099609
18
0.75
0.48999
1
0
0
metastatic
0.3
0.1
dnr after sadm
1
125
4.399414
56
24
36.29688
null
null
null
0.899902
141
null
167
15
750
null
null
<2 mo. follow-up
2.099609
28
1
57.21799
male
0
22
Coma
Coma
0
8
$11-$25k
100
31,051
21,368.125
19,818.8594
21
white
19
29
0.429993
0.356995
1
0
0
no
0.1
0.05
no dnr
22
123
5.5
134
26
39.09375
170
2.199707
0.599976
4.299805
139
7.319336
149
23
1,299
null
0
adl>=4 (>=5 if sur)
0
344
1
45.13599
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
3
null
null
0
8,785
5,756.7539
5,192.65625
8.5
white
23.5
47
0.819946
0.706909
1
0
0
no
null
null
no dnr
8
117
15.298828
110
32
37.69531
null
4.299805
1
0.899902
138
null
179
8
2,920
null
null
null
2.275391
878
0
76.82098
female
0
10
COPD
COPD/CHF/Cirrhosis
6
16
null
0
6,023
4,087.3184
4,534.57812
5.5
white
22.597656
47
0.762939
0.623901
1
0
0
no
0.85
0.75
no dnr
10
55
13.798828
120
6
35.39844
null
2.399902
2.599609
3.099609
140
null
353
132
400
2
0
no(M2 and SIP pres)
0
268
1
84.64294
female
0
6
Coma
Coma
3
18
null
61
7,579
5,323.4609
6,668.03906
12
white
20.199219
9
0.314941
0.242981
1
1
0
no
0.5
0.5
dnr before sadm
-1
59
7.399414
140
40
39.09375
197.125
2.299805
1.199951
1.099854
140
7.459961
124
26
2,275
null
3
<2 mo. follow-up
3
15
1
42.25299
female
1
8
MOSF w/Malig
ARF/MOSF
1
null
null
0
36,798
23,911.3906
22,265.8281
33
white
33.695313
43
0.382996
0.263977
15
0
0
yes
0.2
0.1
dnr after sadm
8
80
18.699219
69
16
37.89844
null
3.099609
0.399963
2.299805
135
null
85
38
null
null
null
<2 mo. follow-up
2.008301
8
1
58.48898
male
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
44
66,086
43,458.0938
45,911.5312
17.25
white
22.398438
51
0.664917
0.567993
9
0
0
no
0.7
0.7
no dnr
29
123
19.398438
110
28
36.19531
261.875
4.399414
0.699951
0.899902
137
7.40918
208
17
2,950
null
0
no(M2 and SIP pres)
0
876
0
75.66095
male
0
6
Lung Cancer
Cancer
2
10
null
0
6,004
3,841.6426
3,366.2793
10
white
16.5
20
0.691895
0.40094
1
0
0
metastatic
1
1
dnr after sadm
1
57
15.699219
70
22
37
null
2.099609
0.599976
6.5
132
null
120
39
0
0
1
null
1
82
1
85.74396
male
1
10
COPD
COPD/CHF/Cirrhosis
4
null
under $11k
37
7,922
5,375.1914
5,476.12891
13.5
white
19.898438
22
0.605957
0.416992
1
0
1
no
0.75
0.6
dnr after sadm
1
69
19.097656
68
8
36.39844
213.3125
3.199707
0.5
8.798828
138
7.389648
103
55
0
null
1
<2 mo. follow-up
1
10
1
71.86896
male
0
11
COPD
COPD/CHF/Cirrhosis
3
14
$11-$25k
0
87,179
59,329.0938
52,506.4688
17.5
white
21
24
0.747925
0.602905
35
0
0
no
0.5
0.4
dnr after sadm
10
77
1.899902
110
20
36.09375
246.65625
null
null
1.399902
136
7.389648
98
60
2,130
0
4
no(M2 and SIP pres)
4
87
1
75.07996
male
0
6
Lung Cancer
Cancer
1
6
$11-$25k
0
3,316
2,170.2188
2,201.96875
8
white
18.398438
9
0.652954
0.347961
1
0
0
metastatic
1
1
no dnr
6
65
11.199219
62
32
35.79688
155.53125
null
null
1.099854
137
7.439453
164
22
1,105
0
1
null
1
60
1
74.81696
female
0
4
Lung Cancer
Cancer
2
12
$11-$25k
0
2,259
1,534.4443
1,526.93945
8
white
15.5
29
0.714966
0.435974
1
0
0
metastatic
1
1
no dnr
4
107
7.199219
130
24
36.09375
95.23438
3.799805
1.5
1
133
7.40918
112
15
1,765
0
1
no(M2 and SIP pres)
1
292
1
65.75494
male
0
15
Colon Cancer
Cancer
3
11
$11-$25k
0
10,259
6,809.7266
7,863.25781
12.666664
white
32.59375
29
0.485962
0.166992
1
1
0
metastatic
0.1
0.01
dnr after sadm
2
99
8.699219
96
20
36.59375
null
3.799805
0.199982
0.699951
127
null
96
10
null
2
3
adl>=4 (>=5 if sur)
3
112
1
68.36096
female
0
7
Lung Cancer
Cancer
2
12
$11-$25k
0
7,018
4,296.5391
3,172.9082
4
white
11.298828
19
0.79895
0.573975
1
0
0
metastatic
0.7
0.3
dnr after sadm
6
108
14.798828
130
44
35.39844
null
null
null
1.099854
155
null
229
68
1,450
null
null
null
1.981689
81
1
66.94299
male
0
6
Coma
Coma
1
null
null
100
18,074
12,242.7344
14,080.75
33
white
30
36
0.066986
0.036995
1
1
0
no
0
0
dnr after sadm
6
74
5.399414
66
32
36.29688
390.4375
null
null
1.599854
139
7.459961
1.599854
27
1,100
null
null
<2 mo. follow-up
2.502441
15
1
76.81
male
0
9
CHF
COPD/CHF/Cirrhosis
5
14
$11-$25k
0
8,619
6,012.4805
5,320.12891
13
white
24.597656
46
0.754883
0.612915
1
1
0
no
0.8
0.6
no dnr
9
75
14.5
142
24
37.89844
132
3
0.5
0.799927
138
7.289062
155
20
1,620
1
2
no(M2 and SIP pres)
2
868
0
66.35498
male
0
63
ARF/MOSF w/Sepsis
ARF/MOSF
2
13
under $11k
0
116,735
73,369.3125
78,425.4375
38.5
white
22.597656
30
0.821899
0.761963
1
0
0
no
0.9
0.9
no dnr
63
61
5.599609
107
16
35.69531
366.625
3.299805
0.599976
1.199951
134
7.439453
255
17
5,300
null
5
adl>=4 (>=5 if sur)
5
866
0
79.16199
male
0
11
CHF
COPD/CHF/Cirrhosis
5
14
null
0
8,505
5,740.9141
4,858.60938
16
hispanic
18.796875
18
0.789917
0.66394
1
0
0
yes
0.6
0.5
dnr after sadm
1
59
6.199219
74
44
35.69531
null
null
0.799927
1.299805
141
null
105
25
null
4
3
no(M2 and SIP pres)
3
343
1
56.92499
female
0
31
COPD
COPD/CHF/Cirrhosis
4
12
null
0
65,550
43,867.9062
48,563.9062
23.5
white
12.599609
22
0.940918
0.899902
1
0
0
no
0.7
0.5
no dnr
31
75
16.398438
49
24
36.39844
202.03125
null
1.199951
1.699951
140
7.209961
280
39
600
0
0
no(M2 and SIP pres)
0
865
0
59.77298
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
18,898
13,060.3906
14,050.4531
4.5
white
16.699219
20
0.868896
0.822998
9
0
0
no
0.99
0.95
no dnr
7
76
11.099609
65
24
36.09375
295.1875
null
0.799927
1.899902
140
7.429688
125
49
null
null
0
no(M2 and SIP pres)
0
864
0
81.20496
female
1
5
Coma
Coma
0
12
$11-$25k
100
6,553
5,017.4922
4,987.24609
23
white
18.699219
18
0.195984
0.136993
1
0
0
no
null
null
dnr after sadm
3
54
7.099609
70
20
37.79688
null
2.5
0.299988
0.799927
136
null
132
3
1,325
null
null
<2 mo. follow-up
2.507813
5
1
40.55298
male
1
4
Coma
Coma
0
0
under $11k
94
5,672
3,994.7324
4,038.21875
17
white
39.796875
41
0.07399
0.040993
1
0
0
no
null
null
dnr after sadm
1
68
10.398438
64
40
36.09375
268
2.5
3.899902
0.799927
137
7.40918
168
25
4,550
null
null
<2 mo. follow-up
2.371094
4
1
37.94098
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
15,509
11,319.9766
10,618.1797
28
white
40.898438
77
0.541992
0.427979
5
1
0
no
0.7
0.6
no dnr
4
81
11.699219
77
20
36.39844
null
2.599609
18
1
140
null
119
10
775
null
2
<2 mo. follow-up
2
4
1
73.03796
male
0
7
CHF
COPD/CHF/Cirrhosis
4
8
under $11k
0
8,538
5,824.7461
5,886.95703
10
white
20.296875
29
0.833984
0.727905
1
1
0
no
0.75
0.6
no dnr
7
76
7
61
24
36.39844
null
2.599609
0.5
1.099854
133
null
98
43
2,100
0
null
null
0.494751
860
0
52.40799
female
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
null
100
15,597
9,914.5703
10,317.7266
43
white
33.59375
87
0.21698
0.119995
1
0
0
no
0.01
0
no dnr
3
41
0.099991
196
36
38.19531
351
3
0.699951
2.199707
145
7.519531
256
91
1,375
null
null
<2 mo. follow-up
3.301758
3
1
47.04398
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$11-$25k
100
22,789
17,392.75
13,695.9766
28
white
47.59375
106
0.003
0
13
1
0
no
0.3
0.2
no dnr
3
133
15.798828
122
40
36.69531
157.5
2.599609
1.599854
1.699951
146
7.429688
173
55
null
null
null
<2 mo. follow-up
3.734375
3
1
69.77399
male
1
7
MOSF w/Malig
ARF/MOSF
4
12
$11-$25k
0
23,180
15,646.0391
18,409.2031
20
white
22.597656
58
0.606934
0.500977
4
0
0
metastatic
0
0
dnr after sadm
6
73
22.398438
104
40
39
142.5
null
null
1.299805
145
7.419922
151
53
1,900
null
0
<2 mo. follow-up
0
7
1
71.64099
male
0
54
MOSF w/Malig
ARF/MOSF
3
14
$25-$50k
0
75,094
50,020.4688
56,390.4062
21.5
white
30.699219
51
0.42395
0.303955
11
0
0
yes
null
null
no dnr
54
56
36.5
70
40
36.59375
254.28125
2.399902
1.199951
1.199951
138
7.419922
217
76
760
null
0
no(M2 and SIP pres)
0
269
1
75.78894
male
0
5
Lung Cancer
Cancer
3
8
$11-$25k
0
2,268
1,554.6572
1,590.97949
14
white
10.298828
13
0.800903
0.577881
1
0
0
metastatic
0.6
0.4
dnr after sadm
2
109
9.5
80
30
38.79688
101.42188
null
null
1.699951
152
7.479492
136
51
3,515
0
0
no(M2 and SIP pres)
0
217
1
83.54596
male
0
5
COPD
COPD/CHF/Cirrhosis
2
7
null
9
3,826
2,541.1699
3,267.94922
13
white
22.699219
34
0.67688
0.506958
1
0
0
no
0.5
0.45
dnr after sadm
3
69
21.898438
122
24
36.79688
null
3.299805
1
1
138
null
177
20
1,245
null
2
no(M2 and SIP pres)
2
853
0
65.29999
male
0
5
Colon Cancer
Cancer
1
10
$11-$25k
0
2,361
1,575.5684
1,510.62988
10
white
17.898438
17
0.803955
0.582886
1
0
0
metastatic
null
null
dnr after sadm
1
79
61.195313
87
24
37
null
2.699707
4.199219
1.599854
135
null
185
14
null
0
null
no(M2 and SIP pres)
0.494751
452
1
67.625
male
0
3
Colon Cancer
Cancer
1
8
under $11k
0
3,589
2,204.9473
2,238.87891
null
white
15.798828
7
0.827881
0.626953
1
0
0
metastatic
0.4
0.05
no dnr
3
76
10.599609
60
32
35.59375
142.84375
null
null
1
141
7.399414
247
21
4,750
null
null
null
1.69458
70
1
70.76794
male
0
8
Lung Cancer
Cancer
1
11
under $11k
0
9,416
5,896.3711
4,755.94922
15.5
white
15.798828
11
0.717896
0.439941
1
0
0
metastatic
0.1
0
dnr after sadm
3
106
17.097656
101
24
36.79688
147.59375
3.299805
0.299988
0.899902
143
7.349609
146
19
null
null
1
<2 mo. follow-up
1
9
1
21.99899
male
0
46
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
9
109,718
77,263.5
83,218.8125
40.75
white
37.5
37
0.696899
0.605957
3
0
0
no
null
null
no dnr
46
113
13.798828
105
32
38.39844
290
null
0.599976
1
138
7.40918
98
20
960
null
6
adl>=4 (>=5 if sur)
6
247
1
83.82495
female
1
31
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
93,539
63,046.8438
66,939.0625
41.25
white
40.09375
84
0.207977
0.113998
15
0
0
no
0.8
0.8
no dnr
31
113
7.199219
77
12
36
null
4
2.099609
1
132
null
196
4
3,995
null
null
<2 mo. follow-up
2.48291
31
1
56.75598
male
0
5
Lung Cancer
Cancer
1
null
null
0
4,327
2,830.0215
2,285.85938
10
white
11.099609
13
0.820923
0.612915
1
0
0
metastatic
0.95
0.8
no dnr
5
59
9.898438
130
10
39.09375
93.32812
2.199707
1.099854
4.899414
138
7.179688
122
70
1,220
null
null
null
1.834473
483
1
83.15094
male
0
7
CHF
COPD/CHF/Cirrhosis
6
8
null
0
5,243
3,663.084
3,145.23828
6
white
26.5
55
0.619995
0.434998
1
1
0
yes
0.8
0.5
no dnr
7
78
13.699219
100
26
36.39844
207.5
2.399902
0.799927
2.099609
137
7.40918
141
50
3,675
4
2
SIP>=30
2
304
1
76.19995
male
0
15
MOSF w/Malig
ARF/MOSF
4
12
$11-$25k
26
90,858
56,111.8438
64,436.3125
18.666656
white
31.597656
66
0.222992
0.125
40
1
0
yes
0.5
0.5
dnr before sadm
-39
74
null
110
10
38.79688
171.40625
null
null
0.899902
141
7.469727
161
28
2,375
null
1
<2 mo. follow-up
1
16
1
66.97894
female
0
9
COPD
COPD/CHF/Cirrhosis
6
13
$11-$25k
0
11,621
7,526.9648
8,539.84375
16
white
20.796875
34
0.80896
0.690918
1
1
0
yes
0.9
0.8
dnr after sadm
1
106
8.599609
110
24
36.39844
261.875
null
0.5
2.799805
137
7.379883
119
60
null
0
0
no(M2 and SIP pres)
0
220
1
68.04395
male
0
20
Coma
Coma
3
8
$11-$25k
55
32,601
21,729.9375
24,082.9062
32.666657
white
25.796875
42
0.352966
0.279968
1
0
0
no
null
null
no dnr
20
123
4.899414
76
20
36.19531
null
3.099609
0.899902
10
139
null
98
62
170
null
0
no(M2 and SIP pres)
0
411
1
92.33398
male
0
8
CHF
COPD/CHF/Cirrhosis
2
12
null
0
3,869
2,705.2637
2,730.59961
2.5
white
23.398438
32
0.698975
0.534912
1
0
0
no
0.8
0.7
no dnr
8
135
0.699951
112
8
39.39844
103.32812
null
null
5.099609
134
7.299805
90
83
133
2
1
no(M2 and SIP pres)
1
838
0
77.61298
male
0
5
COPD
COPD/CHF/Cirrhosis
3
13
$11-$25k
0
3,524
2,386.709
2,585.11914
8
white
13.898438
9
0.870972
0.786987
1
1
0
no
null
null
no dnr
5
71
17.199219
162
30
39.39844
145
1.799805
0.299988
0.599976
126
7.399414
182
12
2,175
0
1
null
1
836
0
86.73499
male
0
11
MOSF w/Malig
ARF/MOSF
4
9
under $11k
0
11,041
7,323.082
7,199.44922
16
white
21.699219
27
0.652954
0.553955
1
0
0
metastatic
0.65
0.1
dnr before sadm
-1
112
11.398438
76
20
36.19531
392
null
0.599976
1.699951
135
7.469727
318
26
2,000
5
5
no(M2 and SIP pres)
5
126
1
50.20697
male
0
4
CHF
COPD/CHF/Cirrhosis
3
12
$25-$50k
0
5,789
3,933.3066
4,027.1582
18
white
18.097656
14
0.911987
0.851929
1
0
0
no
0.8
0.6
no dnr
4
93
4.799805
73
16
37.09375
null
3.799805
0.599976
1
137
null
116
7
1,300
0
0
no(M2 and SIP pres)
0
95
1
50.69098
male
0
4
Lung Cancer
Cancer
1
16
>$50k
0
7,055
4,063.3086
2,812.0293
11
white
9.699219
9
0.846924
0.661987
1
0
0
metastatic
0.7
0.5
no dnr
4
73
7.5
63
20
35
476.1875
null
null
1.199951
132
7.549805
130
32
975
0
0
no(M2 and SIP pres)
0
345
1
40.09299
male
0
22
CHF
COPD/CHF/Cirrhosis
3
18
$25-$50k
0
96,734
68,584.5
49,297.25
7
white
24
43
0.887939
0.812988
1
0
0
no
0.9
0.7
no dnr
22
110
29.5
86
28
36.19531
240
null
0.299988
1.099854
131
7.419922
346
29
3,325
null
0
no(M2 and SIP pres)
0
265
1
60.35599
female
0
10
COPD
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
7,059
4,664.6719
4,985.94922
9.5
white
23.199219
24
0.850952
0.754883
1
1
0
no
1
1
no dnr
10
60
17
155
24
35.19531
414.25
3.299805
1
1.799805
137
7.479492
75
24
null
0
0
null
0
827
0
59.60797
male
0
7
COPD
COPD/CHF/Cirrhosis
5
11
$11-$25k
0
6,488
4,236.8203
4,441.97656
8.5
white
18.296875
22
0.899902
0.832886
1
1
0
no
null
null
dnr after sadm
1
81
7.699219
83
26
37.09375
247.59375
null
null
2
138
7.479492
101
24
2,450
0
0
no(M2 and SIP pres)
0
827
0
85.06494
female
0
13
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
9
9,352
6,178.2148
5,490.21875
11
white
17.296875
30
0.765991
0.62793
1
0
0
no
0.95
0.8
dnr after sadm
1
74
5.899414
77
20
36.59375
204.75
null
1
1
134
7.469727
118
10
3,425
1
6
adl>=4 (>=5 if sur)
6
74
1
68.84296
male
0
12
Lung Cancer
Cancer
3
12
$11-$25k
0
9,346
6,076.0195
5,872.84766
5
white
31.199219
15
0.320984
0.059998
1
0
0
metastatic
1
0.55
dnr after sadm
1
60
26.097656
108
10
38.39844
125
2.299805
15.199219
2.199707
135
7.359375
208
40
3,690
3
2
adl>=4 (>=5 if sur)
2
126
1
68.45197
female
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
4,204
2,914.7578
3,383.51953
9
white
20.597656
22
0.839966
0.785889
1
0
0
no
0.9
0.8
no dnr
4
58
null
66
8
38.79688
184.4375
null
null
null
140
7.469727
null
null
1,842
0
0
no(M2 and SIP pres)
0
825
0
24.18599
female
0
9
Coma
Coma
2
12
under $11k
26
10,604
7,159.0547
7,792.70703
15.5
white
25
25
0.830933
0.797974
1
0
0
no
0.9
0.9
no dnr
9
65
19.699219
118
60
38.59375
73.75
2.5
1.899902
1
143
7.459961
159
29
2,265
0
0
no(M2 and SIP pres)
0
822
0
69.84796
male
0
20
Coma
Coma
2
10
$11-$25k
89
58,550
42,939.125
39,554.25
35.666657
white
24.898438
47
0.13797
0.088989
4
0
0
no
0.5
0.4
dnr after sadm
10
67
null
49
20
35.69531
null
null
null
1.299805
140
null
105
29
2,705
null
2
<2 mo. follow-up
2
24
1
58.185
female
0
21
Coma
Coma
0
12
>$50k
44
28,158
20,724.0938
20,050.7969
21
white
20.5
21
0.644897
0.584961
1
0
0
no
0.8
0.7
no dnr
21
77
null
96
22
37.59375
null
null
null
null
140
null
null
null
null
null
0
no(M2 and SIP pres)
0
820
0
70.35999
female
0
6
Colon Cancer
Cancer
1
12
null
9
4,961
3,193.9883
3,224.61914
16
white
36.195313
53
0.313965
0.056999
1
0
0
metastatic
0.3
0.1
dnr after sadm
1
65
22
98
12
39.79688
165
10.898438
8.798828
1.5
133
7.439453
164
55
2,325
0
null
<2 mo. follow-up
0.494751
51
1
57.547
male
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
>$50k
89
18,402
12,561.375
12,977.5156
28
white
20.699219
26
0.546997
0.43396
4
0
0
no
0.1
0.1
dnr after sadm
3
121
7.399414
83
20
35.79688
328.5625
3.199707
0.299988
5.699219
137
7.439453
195
57
3,425
null
0
<2 mo. follow-up
0
8
1
62.22897
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$11-$25k
0
11,740
8,060.9922
9,392.5625
14
white
19.097656
12
0.872925
0.828979
1
1
0
no
null
null
no dnr
11
101
18.398438
66
24
35.59375
null
null
null
1.199951
137
null
191
16
4,900
null
0
adl>=4 (>=5 if sur)
0
820
0